United Therapeutics Corporation Accounts Receivable, Allowance for Credit Loss
United Therapeutics Corporation (UTHR) had Accounts Receivable, Allowance for Credit Loss of $0 as of 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2018-10-31
- 2018-09-30: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2018-06-30: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2018-03-31: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2017-12-31: Accounts Receivable, Allowance for Credit Loss $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-10-31 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 |
| 2017-12-31 | $0.00 10-Q · filed 2018-05-02 |
| 2017-09-30 | $0.00 10-Q · filed 2018-10-31 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |